ArticleFrontiers in bioengineering and biotechnology2022

Assessment of Strategies for Safe Drug Discontinuation and Transition of Denosumab Treatment in PMO-Insights From a Mechanistic PK/PD Model of Bone Turnover.

Javier Martínez-Reina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.